NYSE:UNH | Cash Flow Statement | UNITEDHEALTH GROUP INC

Complete source-backed cash-flow history.

Available history
2007-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$5.48B
2026-03-31$6.28B$8.91B$763M-$2.45B$0.00$2.01B-$2.99B
2025-12-31$10M$1.11B$948M-$2.61B$0.00$2B-$1.03B
2025-09-30$2.35B
2025-06-30$3.41B
2025-03-31$6.29B$5.46B$898M-$74M$3B$1.91B$99M
2024-12-31$5.54B$2.37B$912M-$1.12B$4.97B$1.93B-$8.34B
2024-09-30$6.06B
2024-06-30$4.22B
2024-03-31-$1.41B$1.14B$743M-$6.34B$3.07B$1.73B$8.23B
2023-12-31$5.46B-$5.19B$959M-$1.19B$1.5B$1.74B-$7.16B
2023-09-30$5.84B
2023-06-30$5.47B
2023-03-31$5.61B$16.33B$760M-$11.02B$2B$1.54B$13.19B
2022-12-31$4.76B-$4.53B$866M-$15.37B$1B$1.54B$4.39B
2022-09-30$5.26B
2022-06-30$5.07B
2022-03-31$5.03B$5.32B$555M-$3.67B$2.5B$1.36B$2.3B
2021-12-31$4.07B$3.22B$695M$716M$1.05B$1.37B-$3.63B
2021-09-30$4.09B
2021-06-30$4.27B
2021-03-31$4.86B$6.01B$568M-$3.71B$1.65B$1.18B$787M
2020-12-31$2.21B$6.1B$574M-$5.18B$1.71B$1.18B-$1.6B
2020-09-30$3.17B
2020-06-30$6.64B
2020-03-31$3.38B$2.94B$469M-$1.53B$1.69B$1.02B$9.3B
2019-12-31$3.54B$6.21B$650M-$1.39B$399M$1.02B-$6.21B
2019-09-30$3.54B
2019-06-30$3.29B
2019-03-31$3.47B$3.23B$562M-$1.42B$3B$860M-$272M
2018-12-31$3.04B$2.4B$558M-$1.14B$850M$866M-$672M
2018-09-30$3.19B
2018-06-30$2.92B
2018-03-31$2.84B$8.37B$477M-$4.52B$2.65B$722M$2.42B
2017-12-31$3.62B-$2.58B$632M-$2.7B$327M$727M$1.02B
2017-09-30$2.49B
2017-06-30$2.28B
2017-03-31$2.17B$6.46B$507M-$2.29B$682M$596M$1.53B
2016-12-31$1.68B-$1.41B$485M-$614M$163M$595M-$351M
2016-09-30$1.97B
2016-06-30$1.75B
2016-03-31$1.61B$2.32B$425M-$4.18B$500M$477M$1.5B
2015-12-31$1.22B$3.51B$484M-$975M$70M$476M$409M
2015-09-30$1.6B
2015-06-30$1.59B
2015-03-31$1.41B$2.27B$373M-$1.53B$896M$357M$496M
2014-12-31$1.51B$2.43B$404M-$676M$984M$358M-$1.48B
2014-09-30$1.6B
2014-06-30$1.41B
2014-03-31$1.1B$1.41B$353M-$603M$911M$276M-$573M
2013-12-31$1.43B$1.07B$321M-$816M$822M$279M-$1.26B
2013-09-30$1.57B
2013-06-30$1.44B
2013-03-31$1.19B$1.05B$323M-$904M$543M$216M$1.5B
2012-12-31$1.24B$1.68B$284M-$4.19B$490M$217M$2B
2012-09-30$1.56B
2012-06-30$1.34B
2012-03-31$1.39B$3.59B$269M-$2.4B$991M$168M$1.04B
2011-12-31$1.26B-$415M$261M-$1.25B$900M$170M-$2.59B
2011-09-30$1.27B
2011-06-30$1.27B
2011-03-31$1.35B$1.22B$213M-$1.34B$620M$135M$780M
2010-12-31$1.04B$1.44B$330M-$1.71B$625M$136M-$190M
2010-09-30$1.28B$139M
2010-06-30$1.12B$140M
2010-03-31$1.19B$1.21B$132M-$583M$626M$0.00-$502M
2009-12-31$944M$1.28B$256M-$862M$233M$0.00-$153M
2009-09-30$1.04B
2009-06-30$859M
2009-03-31$984M$1.11B$160M-$156M$689M-$495M
2008-12-31$726M$1.6B$193M$278M$179M$0.00-$534M
2008-09-30$920M
2008-06-30$337M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$12.06B$19.7B$3.62B-$8.69B$5.55B$7.92B-$11.64B
2024-12-31$14.41B$24.2B$3.5B-$20.53B$9B$7.53B-$3.51B
2023-12-31$22.38B$29.07B$3.39B-$15.57B$8B$6.76B-$11.53B
2022-12-31$20.12B$26.21B$2.8B-$28.48B$7B$5.99B$4.23B
2021-12-31$17.29B$22.34B$2.45B-$10.37B$5B$5.28B-$7.46B
2020-12-31$15.4B$22.17B$2.05B-$12.53B$4.25B$4.58B-$3.59B
2019-12-31$13.84B$18.46B$2.07B-$12.7B$5.5B$3.93B-$5.63B
2018-12-31$11.99B$15.71B$2.06B-$12.39B$4.5B$3.32B-$4.37B
2017-12-31$10.56B$13.6B$2.02B-$8.6B$1.5B$2.77B-$3.44B
2016-12-31$7.02B$9.8B$1.71B-$9.36B$1.28B$2.26B-$1.01B
2015-12-31$5.81B$9.74B$1.56B-$18.4B$1.2B$1.79B$12.24B
2014-12-31$5.62B$8.05B$1.53B-$2.53B$4.01B$1.36B-$5.29B
2013-12-31$5.63B$6.99B$1.31B-$3.09B$3.17B$1.06B-$4.95B
2012-12-31$5.53B$7.16B$1.07B-$8.65B$3.08B$820M$471M
2011-12-31$5.14B$6.97B$1.07B-$4.17B$2.99B$651M-$2.49B
2010-12-31$4.63B$6.27B$878M-$5.34B$2.52B$449M-$1.61B
2009-12-31$3.82B$5.63B$739M-$976M$1.8B$36M-$2.28B
2008-12-31$2.98B$4.24B$791M-$5.07B$2.68B$37M-$605M
2007-12-31$4.65B$5.88B$871M-$4.15B$6.6B$40M-$3.19B

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.